CONCLUSION

Johnson & Johnson was incorporated in the State of New Jersey in 1887. The Company is engaged in the research and development, manufacture and sale of a range of products in the health care field. It is a holding company, which has more than 250 operating companies conducting business in virtually all countries of the world. Johnson. Johnson & Johnson's operating companies are organized into three business segments: Consumer, Pharmaceutical and Medical Devices and Diagnostics. The Consumer segment includes a range of products used in the baby care, skin care, oral care, wound care and women's health care fields, as well as nutritional and over-the-counter pharmaceutical products. The Baby Care franchise includes the JOHNSON'S(r) Baby line of products. Major brands in the Skin Care franchise include the AVEENO(r); CLEAN & CLEAR(r); JOHNSON'S(r) Adult; NEUTROGENA(r); RoC(r); LUBRIDERM(r); Beijing Dabao Cosmetics Co., Ltd.; and Vendome product lines. The Oral Care franchise includes the LISTERINE(r) and REACH(r) oral care lines of products. Major brands in the Womens Health franchise are the CAREFREE(r) Pantiliners and STAYFREE(r) sanitary protection products. The nutritional and over-the-counter lines include SPLENDA(r), No Calorie Sweetener; the family of TYLENOL(r) acetaminophen products; SUDAFED(r) cold, flu and allergy products; ZYRTEC(r) allergy products; MOTRIN(r) IB ibuprofen products; and

PEPCID(r) AC Acid Controller from Johnson & Johnson Merck Consumer Pharmaceuticals Co. The Pharmaceutical segment includes products in the following therapeutic areas: anti-infective, antipsychotic, cardiovascular, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, urology and virology. Key products in the Pharmaceutical segment include: REMICADE(r) a biologic approved for the treatment of Crohn's disease, ankylosing spondylitis, psoriasis, psoriatic arthritis, ulcerative colitis, and use in the treatment of rheumatoid arthritis; TOPAMAX(r) approved for adjunctive and monotherapy use in epilepsy, as well as for the prophylactic treatment of migraines; PROCRIT(r) biotechnology-derived product that stimulates red blood cell production; RISPERDAL(r) oral a medication that treats the symptoms of schizophrenia, bipolar mania and irritability associated with autistic behavior in indicated patients. RISPERDAL(r) CONSTA(r), a long-acting injectable, and INVEGATM Extended-Release tablets, for the treatment of schizophrenia; LEVAQUIN(r) and FLOXIN(r), both in the anti-infective field; CONCERTA(r), a product for the treatment of attention deficit hyperactivity disorder; ACIPHEX(r)/PARIET(r), a proton pump inhibitor co-marketed with Eisai Inc.; and DURAGESIC(r)/Fentanyl Transdermal a treatment for chronic pain that offers a novel delivery system. The Medical Devices and Diagnostics segment includes a range of products distributed to wholesalers,

hospitals and retailers, used mainly in the professional fields by physicians, nurses, therapists, hospitals, diagnostic laboratories and clinics. In all of their product lines, Johnson & Johnson's operating companies compete with companies large and small, located throughout the world. Most of Johnson & Johnson's businesses are subject to varying degrees of governmental regulation in the countries in which operations are conducted, and the general trend is toward increasingly stringent regulation. Website: www.jnj.com Industry: Pharmaceuticals Employees: 118,700 (12/12/2008)

Report Summary
This company profile offers a comprehensive analysis of the organization, its business segments, and competitors. It analyzes the business and marketing strategies adopted by the company, to gain a competitive edge in the industry. The profile also evaluates the strengths of the company and the opportunities present in the market. This profile is of immense help to management consultants, analysts, market research organizations and corporate advisors. The objective and scope of various sections of our company profile has been discussed below. Company Summary This section presents the key facts & figures, business description, products & services offered and corporate timeline of the company. Company Analysis It involves analysis of the company at three levels ' segments, organizational structure and ownership composition. Both business and geographic segments are analyzed alongwith their recent financial performance. It further discusses the major subsidiaries of the company and the recent merger & acquisitions.

Business Developments This section examines the significant developments that have taken place in the company. It is a form of news analysis where the most critical company news is discussed. Discussion of Business Strategies This section talks about the current and future strategies of the company. All business, marketing, financial and organizational strategies are discussed here. SWOT Our SWOT Analysis is a valuable step in assessing your company's strengths, weaknesses, opportunities, and threats. It offers powerful insight into the critical issues affecting a business. Financial Performance It discusses the most recent financials of the company and also compares the historical sales & income figures with the current and projected figures. The objective is to evaluate the financial health of the company. The analyst opinion and stock performance help us in evaluating the performance of the company from an investor's viewpoint. Competition Synopsis This section compares the company with its peer group. The comparable analysis and stock movement are aimed at giving an overview of the competitive landscape in the industry and the company's positioning in its peer group.

Johnson & Johnson (NYSE: JNJ) is a global American pharmaceutical, medical devices and consumer packaged goods manufacturer founded in 1886. Its common stock is a component of the Dow Jones Industrial Average and the company is listed among the Fortune 500. Johnson & Johnson is known for its corporate reputation, consistently ranking at the top of Harris Interactive's National Corporate Reputation Survey,[2] ranking as the world's most respected company by Barron's Magazine,[3] and was the first corporation awarded the Benjamin Franklin Award for Public Diplomacy by the U.S. State Department for its funding of international education programs.[4] The corporation's headquarters is located in New Brunswick, New Jersey, United States. Its consumer division is located in Skillman, New Jersey. The corporation includes some 250 subsidiary companies with operations in over 57 countries. Its products are sold in over 175 countries. J&J had worldwide pharmaceutical sales of $24.6 billion for the full-year 2008. Johnson & Johnson's brands include numerous household names of medications and first aid supplies. Among its well-known consumer products are the Band-Aid Brand line of bandages, Tylenol medications, Johnson's baby products, Neutrogena skin and beauty products, Clean & Clear facial wash and Acuvue contact lenses. (Johnson & Johnson should not be confused with S.C. Johnson, another large consumer packaged goods maker.)

A STUDY ON BUSINESS ENVIRONMENT OF JOHNSON AND JOHNSON COMPANY

PRESENTED BY
NAME PRIYADARSHINI JEEVA.

STD FYBMS.

ROLL NO. 14038.

SUBJECT BUSINESS ENVIRONMENT.

SUBMITTED TO RAHUL SIR.

INDEX
SR NO. TOPIC 1 INTRODUCTION 2 3 4 5 6 7 8 9 HISTORY BACKGROUND PRODUCT AND SERVICES SWOT ANALYSIS COMPONENTS OF BUSINESS ENVIRONMENT CONCLUSION RECOMMENDATION REPROT SUMMARY